Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Carl Zeiss Meditec : acieves strong revenue and EBIT growth in first three months 2018/19

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/14/2019 | 09:55am EDT

DGAP-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Preliminary Results/Quarter Results
Carl Zeiss Meditec AG acieves strong revenue and EBIT growth in first three months 2018/19

14-Jan-2019 / 15:47 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Carl Zeiss Meditec AG achieves strong revenue and EBIT growth in first three months 2018/19
 
Jena, January 14, 2019

Carl Zeiss Meditec (ISIN: DE0005313704) has achieved revenue of approximately EUR 324 million in the first three months of fiscal year 2018/19, based on preliminary data. This corresponds to revenue growth of around 10% vs. the previous year's value of EUR 294.7 million. Currency effects only had a minor impact on growth.

In the same period, earnings before interest and taxes (EBIT) increased significantly to EUR 48.1 million (prev. year EUR 38.9 million). This corresponds to an EBIT margin (EBIT in percent of revenue) of 14.9% (prev. year 13.2%). EBIT was positively impacted by temporarily reduced research & development expenses. For fiscal year 2018/19, the company still expects an EBIT margin between 14% to 16%.

The 3-months quarterly statement for fiscal year 2018/19 will be published on February 11, 2019.
 
 

Contact for investors and press
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Tel.: +49 3641 220-116
E-Mail: investors.meditec@zeiss.com


14-Jan-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail: investors.meditec@zeiss.com
Internet: www.zeiss.de/meditec-ag/ir
ISIN: DE0005313704
WKN: 531370
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange

 
End of Announcement DGAP News Service

765851  14-Jan-2019 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=765851&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CARL ZEISS MEDITEC AG
08/12CARL ZEISS MEDITEC : continues strong growth trend after nine months of 2018/19
AQ
08/09EUROPE : Italy leads European shares lower on political uncertainty
RE
08/09GLOBAL MARKETS LIVE : Bayer, Huawei, Airbus, Occidental Petroleum…
08/09CARL ZEISS MEDITEC : continues strong growth trend after nine months of 2018/19
EQ
08/02CARL ZEISS MEDITEC AG : Preliminary announcement of the publication of quarterly..
EQ
07/16INFORMATION PURSUANT : Carl Zeiss Meditec is aiming for the upper end of its rev..
PU
07/15CARL ZEISS MEDITEC : is aiming for the upper end of its revenue forecast for the..
EQ
06/19EUROPE : European stocks tread water, all eyes on Fed
RE
06/18A pivotal month of June
06/04A war on all fronts
More news
Financials (EUR)
Sales 2019 1 428 M
EBIT 2019 264 M
Net income 2019 168 M
Finance 2019 663 M
Yield 2019 0,67%
P/E ratio 2019 52,6x
P/E ratio 2020 45,0x
EV / Sales2019 5,76x
EV / Sales2020 5,23x
Capitalization 8 886 M
Chart CARL ZEISS MEDITEC AG
Duration : Period :
Carl Zeiss Meditec AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARL ZEISS MEDITEC AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Average target price 92,38  €
Last Close Price 99,55  €
Spread / Highest target 0,45%
Spread / Average Target -7,20%
Spread / Lowest Target -17,6%
EPS Revisions
Managers
NameTitle
Ludwin Monz President & Chief Executive Officer
Michael Kaschke Chairman-Supervisory Board
Justus Felix Wehmer Chief Financial Officer
Markus Guthoff Member-Supervisory Board
Cornelia Grandy Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
CARL ZEISS MEDITEC AG45.46%9 796
THERMO FISHER SCIENTIFIC31.97%119 202
DANAHER CORPORATION36.39%101 163
INTUITIVE SURGICAL9.34%60 303
BOSTON SCIENTIFIC CORPORATION18.68%58 240
EDWARDS LIFESCIENCES CORPORATION40.43%45 649